Nasdaq Stockholm flags 2cureX as potentially non-compliant with First North listing rules on ongoing business operations

  • 2cureX faces a Nasdaq Stockholm review that could find it non-compliant with continued listing rules on ongoing business operations.
  • Nasdaq’s preliminary assessment indicates the company may not currently meet First North Growth Market requirements for ongoing operations.
  • Nasdaq requested additional supporting materials by Aug. 14, 2026; extensive documentation has been submitted to support continued operations.
  • Boards moved to accelerate reintegration of privately held 2cureX A/S into the listed company, targeting completion in Aug. 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 2cureX AB published the original content used to generate this news brief on July 06, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.